Chief Compliance Officer, General Counsel, Company Secretary
Chief Compliance Officer, General Counsel, Company Secretary
18.38K
--
Dr. Javier San Martin, M.D.
Dr. Javier San Martin, M.D.
Chief Medical Officer
Chief Medical Officer
15.89K
--
Mr. Robert Renninger
Mr. Robert Renninger
Senior Vice President - Finance, Accounting
Senior Vice President - Finance, Accounting
15.85K
+18.89%
Ms. Kelly A. Romano
Ms. Kelly A. Romano
Independent Chairwoman of the Board
Independent Chairwoman of the Board
8.07K
--
Mr. Grant E. Pickering
Mr. Grant E. Pickering
Independent Director
Independent Director
2.58K
--
James A. Johnson ,
James A. Johnson ,
Independent Director
Independent Director
500.00
--
Ms. Barbara Kosacz, J.D.
Ms. Barbara Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Joseph (Joe) Edelman
Mr. Joseph (Joe) Edelman
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Mark James Litton, Ph.D.
Dr. Mark James Litton, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
59.89K
--
Dr. Kevin Church, Ph.D.
Dr. Kevin Church, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
25.18K
+17.86%
Mr. Mark Worthington
Mr. Mark Worthington
Chief Compliance Officer, General Counsel, Company Secretary
Chief Compliance Officer, General Counsel, Company Secretary
18.38K
--
Dr. Javier San Martin, M.D.
Dr. Javier San Martin, M.D.
Chief Medical Officer
Chief Medical Officer
15.89K
--
Mr. Robert Renninger
Mr. Robert Renninger
Senior Vice President - Finance, Accounting
Senior Vice President - Finance, Accounting
15.85K
+18.89%
Ms. Kelly A. Romano
Ms. Kelly A. Romano
Independent Chairwoman of the Board
Independent Chairwoman of the Board
8.07K
--
FAQs
Who are the top five shareholders of LeonaBio Ord Shs?
The top five shareholders of LeonaBio Ord Shs are: Dr. Mark James Litton, Ph.D.
How many institutions hold shares of LeonaBio Ord Shs (LONA)?
As of 2026Q1, 120 institutions hold shares of LeonaBio Ord Shs, with a combined market value of approximately 6.66M, accounting for 70.97% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 2319889.00.